Skip to content
10-Q

Quarterly Report

GLOBEIMMUNE INC

0001564590-16-019134

← back to feed
Filed
May 12, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Apr 29, 2016 5.75M sh
Cash And Equivalents Q1 2016 · Mar 31, 2016 $8.69M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $9.9M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $14.36M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $16.81M
Stockholders Equity Q1 2016 · Mar 31, 2016 $2.15M
Stockholders Equity Q1 2016 · Dec 31, 2015 $2.99M
Current Liabilities Q1 2016 · Mar 31, 2016 $4.14M
Current Liabilities Q1 2016 · Dec 31, 2015 $4.23M
Total Liabilities Q1 2016 · Mar 31, 2016 $7.62M
Total Liabilities Q1 2016 · Dec 31, 2015 $8.52M
Current Assets Q1 2016 · Mar 31, 2016 $9.45M
Current Assets Q1 2016 · Dec 31, 2015 $11.09M
Total Assets Q1 2016 · Mar 31, 2016 $9.77M
Total Assets Q1 2016 · Dec 31, 2015 $11.51M
Sga Expense Q1 2016 · Mar 31, 2016 $933.25K
Sga Expense Q1 2016 · Mar 31, 2015 $1.19M
Rd Expense Q1 2016 · Mar 31, 2016 $852.62K
Rd Expense Q1 2016 · Mar 31, 2015 $1.48M
Net Income Q1 2016 · Mar 31, 2016 −$862.21K
Net Income Q1 2016 · Mar 31, 2015 −$1.56M
Revenue Q1 2016 · Mar 31, 2016 $942.75K
Revenue Q1 2016 · Mar 31, 2015 $1.19M
Capex Q1 2016 · Mar 31, 2015 $23.94K